Form 4: Collegium Pharmaceutical EVP Thomas B. Smith Sells 995 Shares of Common Stock

EVP and Chief Medical Officer of Collegium Pharmaceutical, Thomas B. Smith, sold 995 shares of common stock at a price of $36.764 per share on February 29, 2024.

Summary

• On February 29, 2024, Thomas B. Smith, EVP and Chief Medical Officer of Collegium Pharmaceutical, sold 995 shares of common stock.
• The transaction was executed at a price of $36.764 per share.
• Following the transaction, Smith directly owns 63,409 shares of Collegium Pharmaceutical common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings are publicly available and provide transparency into insider transactions.

Stakeholder Impact

• The sale of shares by an executive could be perceived in various ways by stakeholders.
• Some might see it as a lack of confidence in the company's future, while others might view it as a personal financial decision.

Key Dates